Logo for Bioxytran Inc

Bioxytran Investor Relations Material

Latest events

Logo for Bioxytran

Q3 2024

29 Oct, 2024
Logo for Bioxytran

Q2 2024

14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Bioxytran Inc

Access all reports
Bioxytran Inc. is a biotechnology company focused on developing therapies for fibrotic and viral diseases. The company specializes in glycovirology, using carbohydrate-based drugs to target viral infections and inflammatory conditions. Its research includes treatments for diseases such as COVID-19 and pulmonary fibrosis, aiming to improve oxygen delivery and tissue regeneration. The company is headquartered in Needham, Massachusetts, and its shares are listed on the OTCQB.